← Back to Search

Light therapy B via the Re-Timer® for Stress

N/A

Waitlist Available

Led By Helen Burgess

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and treatment week 2 and treatment week 4

Awards & highlights

Study Summary

This trial looks at the effects of different lengths of time exposed to morning light on emotional processing in the brain.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and treatment week 2 and treatment week 4

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and treatment week 2 and treatment week 4

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and treatment week 2 and treatment week 4 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Amygdala Reactivity as Measured by Blood-oxygen-level-dependent (BOLD) Functional Magnetic Resonance Imaging (fMRI) Signal

Trial Design

3Treatment groups

Experimental Treatment

Group I: Light therapy C via the Re-Timer®Experimental Treatment1 Intervention

-60 minutes/day

Group II: Light therapy B via the Re-Timer®Experimental Treatment1 Intervention

-30 minutes/day

Group III: Light therapy A via the Re-Timer®Experimental Treatment1 Intervention

-15 minutes/day

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Light therapy B via the Re-Timer®

2020

N/A

~50

Light therapy C via the Re-Timer®

2020

N/A

~50

Light therapy A via the Re-Timer®

2020

N/A

~50

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor

1,795 Previous Clinical Trials

6,373,886 Total Patients Enrolled

National Institute of Mental Health (NIMH)NIH

2,783 Previous Clinical Trials

2,689,099 Total Patients Enrolled

Helen BurgessPrincipal Investigator - University of Michigan

University of Michigan

1 Previous Clinical Trials

60 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment open to persons of 25 years or older?

"The age range for inclusion in this medical trial is between 18 and 60 years old, as detailed within the criteria."

Answered by AI

How many individuals are being included in this clinical experiment?

"Affirmative. According to clinicaltrials.gov's records, this trial is still recruiting participants and began doing so on January 24th 2020. The last update was made in November 6th 2022, with 66 patients sought from one site being the goal of recruitment."

Answered by AI

What criteria must a person fulfill to be eligible for this trial?

"This psychological trial is actively seeking 66 volunteers, aged 18 to 60. Qualifying participants must display symptoms of traumatic stress, possess normal or corrected vision, be right-handed, have proficiency in English and physically able for study visits."

Answered by AI

Are there any remaining spots for individuals to join the clinical trial?

"Indeed, clinicaltrials.gov confirms that this clinical trial is actively recruiting; it was first posted on January 24th 2020 and most recently updated on November 6th 2022. 66 participants are needed from a single medical facility."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity

Helen Burgess 2020. "Morning Light Treatment for Traumatic Stress: The Role of Amygdala Reactivity". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04117347.